Ipsen (I7G.F) Stock Highlights

99.4 | +0.66%

2025-05-01 01:59:48

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.

Statistics

Range Today

99.4 99.4

Volume Today 30

Range 1 Year

90.2 125.3

Volume 1 Year 2.08K

Range 3 Year

80.4 129.7

Volume 3 Year 10.07K

Range 10 Year

36.84 153.6

Volume 10 Year 38.04K

Highlights

Market Capitalization 9.41B (mid)

Floating Shares 28.7M

Current Price 99.4

Price To Earnings 23.01

Price To Revenue 2.23

Price To Book 1.94

Earnings Per Share 4.27

Dividend Yield 1.49%

Dividend Per Share 1.4

Payout Ratio 28.1%

Performance

Latest +0.66%

1 Month -6.31%

3 Months -16.05%

6 Months -11.57%

1 Year -11.17%

3 Years +2.58%

5 Years +52.45%

10 Years +99.59%

Benchmarks

Market Capitalization

0 / 54

Gross Profits

0 / 39

Total Revenue

0 / 50

Total Rank

0 / 54

Free Cashflow

0 / 54

Performance 5 years

0 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.